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It is has been shown that the majority of T. cruzi strains isolated from Mexico belong to the T. cruzi I (TCI). The immune
response produced in response to Mexican T. cruzi I strains has not been well characterized. In this study, two Mexican T. cruzi
I strains were used to infect Balb/c mice. The Queretaro (TBAR/MX/0000/Queretaro)(Qro) strain resulted in 100% mortality. In
contrast, no mortality was observed in mice infected with the Ninoa (MHOM/MX/1994/Ninoa) strain. Both strains produced
extended lymphocyte inﬁltrates in cardiac tissue. Ninoa infection induced a diverse humoral response with a higher variety of
immunoglobulin isotypes than were found in Qro-infected mice. Also, a stronger inﬂammatory TH1 response, represented by
IL-12p40, IFNγ, RANTES, MIG, MIP-1β,and MCP-1production was observed in Qro-infected mice when compared with Ninoa-
infected mice. We propose that an exacerbated TH1 immune response is a likely cause of pathological damage observed in cardiac
tissue and the primary cause of death in Qro-infected mice.
1.Introduction
Chagas’ disease is a major endemic disease caused by the
protozoanTrypanosomacruzi.Thisparasiticdiseaseiswidely
distributed throughout Latin America, aﬀecting 18 million
people [1]. In the past, it was believed that Chagas’ disease
was very rare in the northern part of America, including
Mexico, as few human disease cases were reported. More
recently, however, it has been estimated that there are as
many as two million infected individuals and more than
72000casesinMexicoandCentralAmerica[2].Eventhough
these ﬁgures are only estimates, other ﬁeld studies support
the notion that the prevalence of T. cruzi infection might
be higher in some regions of the country than previously
thought [3–5]. T. cruzi has also been repeatedly found
infecting insects and mammals in Mexico and the United
States of America [6–8].
T. cruzi strains have been divided into six discrete typing
units (DTUs) according to their genetic background. These
groups are designed the T. cruzi It oV I[ 9]. The geographical
distribution of these groups indicate that T. cruzi II to VI
are the main causal agent of Chagas’ disease in the southern
parts of South America, with T. cruzi I only present in the
sylvatic cycle [9–11]. In contrast, T. cruzi Ih a sb e e nr e p o r t e d
as the primary parasite present in human cases in Colombia,
Venezuela, and Central America [12–14]. In Mexico, most of
the T. cruzi strains that have been genetically analyzed to date
belong to the T. cruzi Ig r o u p[ 15–17]. We have reported that
this Mexican T. cruzi I strain possesses diﬀerent biological
characteristics such as growth rates, metaciclogenesis, and
infectivityinvitro[15].However,thepathologyandimmune
response that these strains can induce has largely gone
unstudied.
Knowledge of the pathology and immune response to
T. cruzi infection has been beneﬁciated by data obtained
from murine models. These models have shown that the
innate and adaptive immune responses play an important
role in parasite control, depending on the combined action2 Journal of Biomedicine and Biotechnology
of various cellular types including NK, CD4+ and CD8+ as
well as on the production of antibodies by B cells [18, 19].
Resistance to T. cruzi infection has been associated with the
production of the pro-inﬂammatory cytokines IL-12 and
IFN-γ and with the local production of RANTES, MIP-1α,
MIP-1β and MCP-1. These cytokines activate the production
of nitric oxide by macrophages, which is responsible for
elimination of the parasite [20–23]. TNF-α has also been
associated with macrophage activation as a secondary signal
for nitric oxide production [24]. In contrast, the Th2
cytokines IL-10, IL-4 and TGF-β are associated with parasite
susceptibility [25, 26].
Since the majority of published data has been obtained
from studying T. cruzi II-VI-infected mice and the genetic
diﬀerences between T. cruzi II-VI and T. cruzi I strains are
large, the pathology and immune response to Mexican T.
cruzi I Qro and Ninoa strains were evaluated in a murine
model. Even though these two strains were genetically
indistinguishable using the genetic markers available until
recently [16, unpublished data], diﬀerences in pathology and
immune responses were found in mice infected with both
strains.
2.MaterialsandMethods
Parasites.M e x i c a nT. cruzi I Qro (TBAR/MX/0000/
Queretaro) and Ninoa (MHOM/MX/1994/Ninoa) strains
were used in this study [15, 16]. The Qro strain was isolated
from the Triatoma barberi vector from the Queretaro State
in Central Mexico. The Ninoa strain was obtained from a
human case in Oaxaca State in the southern Paciﬁc coast of
Mexico. Both strains were maintained by serial passage in
Balb/c mice.
Mice. Six–eight-week-old female Balb/c mice were
obtained from the Animal House of the Instituto de Inves-
tigaciones Biomedicas (UNAM, Mexico City, Mexico) and
maintained under standard conditions. Groups of 9 to 12
mice were injected intraperitoneally with 1 × 104 or 1 × 105
blood-form trypomastigotes (BT). Parasitemia was deter-
mined every third day by blood microscopy observation.
Groups of 28 mice were used for daily monitored of survival.
All animal research followed the Instituto de Investigaciones
Biomedicas ethical committee’s guidelines.
Histopathological Evaluation. Groups of four Ninoa- or
Qro-infected mice were sacriﬁced under anesthesia on day
21 post infection (pi). Groups of three age-matched control
miceweresacriﬁcedatthesametimepoint.Themyocardium
was ﬁxed in neutral 4% paraformaldehyde and embedded
in paraﬃn. Serial 5-μm sections were prepared and stained
with hematoxylin and eosin (H-E) and examined using light
microscopy on an Optiphot-2 microscope (Nikon).
The inﬂammatory inﬁltrates were subdivided into focal
and diﬀuse inﬁltrates, depending on how closely the inﬂam-
matory cells were associated [27].
Characterization of Speciﬁc Antibodies and Antigens.
Speciﬁc T. cruzi antibodies were detected by an indirect
ELISA using an epimastigote extract as previously described
[28]. The antibody isotypes and antigens recognized by the
speciﬁc antibodies were determined at days 0, 4, 8, 12, 16,
20, 25, 30, 35, 40, 50, 60 70, 80, 90, 100, and 150 post-
infection by western blot. Brieﬂy, proteins from the total
extract from both strains were separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis and transferred to
nitrocellulose membranes. After overnight saturation in PBS
containing 10% skim milk at 4◦C with constant shaking,
the nitrocellulose membrane was cut into strips that were
individually incubated (2hrs at 37
◦C) with 1ml of mouse
serum diluted 1:500 in PBS/10% skim milk. Each strip was
washed three times with PBS-0.1% Tween 20 and incubated
with goat antimouse IgG1, IgG2a, IgG2b, IgG3, IgA and
IgM (diluted 1:2,000) for 2 hrs at room temperature.
Then the strips were washed as above and a peroxidase-
conjugated antigoat antibody was added. After washing, the
reaction was developed with 0.5μg/mL of diaminobenzidine
in PBS containing 0.02% H2O2. The reaction was stopped
with water. Positive (chronically infected mice) and negative
control (non infected mice) sera were included in each
experiment.
T Cell Proliferation Assay. Spleens were removed asepti-
cally from anesthetized Balb/c mice at 15, 21 and 98 days
post-infection and spleen cell suspensions were prepared.
Culturesofspleencellsuspensions(1×105 inRPMImedium
containing10%heatinactivatedserum,100U/mLpenicillin,
100μg/mL streptomycin and, 100U/mL gentamicin) were
set up in triplicate in microculture plates. Then cells were
stimulated with 1μg/mL of concanavalin A (Con A) or
20μg/mL of epimastigote total extract. After culturing for 48
hours at 37◦Cw i t h5 %C O 2, 1.0 μCi of ( 3H) thymidine per
well was added. Twenty hours later, cells were harvested onto
ﬁlters, dried and placed in scintillation ﬂuid and counted
in a scintillation counter. The stimulation index (SI) was
obtained by dividing the infected cells’ counts per minute
between the control group’s counts [29].
CD4+ and CD8+ Cells.F A C Sa n a l y s i sw a su s e dt o
quantify CD4+ and CD8+ lymphocytes. Brieﬂy, spleen cell
suspensions (1 × 106) were obtained from infected and
control mice and were stained with 1μg of FITC-labeled
antibodies against CD4 or PE-labeled antibodies against
CD8. Cells were analyzed by FACS (Becton and Dickinson)
[29].
Cuantiﬁcation of Murine Cytokines.L e v e l so fI F N - γ,I L -
12p40, IL-4 and IL-10 cytokines in sera (diluted 1:10) were
assayed in a two-site ELISA following the manufacturer’s
instructions (ENDOGEN, Cambridge). Cytokine levels were
calculated by reference to a standard curve constructed with
recombinant cytokines included in the commercial kit.
RT-PCR Assay for Measuring Expression of Chemokine
mRNA. RNA was isolated from cardiac muscle of infected
mice and controls by TRIZOL (Invitrogen). Before RT-
PCR, RNA was incubated with ampliﬁcation grade DNasas
I (Invitrogen). Levels of MIG (CXCL9), MCP-1(CCL2),
MIP-1β (CCL4), RANTES (CCL5), and β-actin (as control)
mRNA were determined by SuperScript One-step RT-PCR
with Taq Platinum (Invitrogen). The primer (sense and
antisense) sequences, the number of cycles, and expected
product sizes have been published previously [21, 30]. For
all primer pairs, a negative control (without template) wasJournal of Biomedicine and Biotechnology 3
run in parallel. Reactions were performed using a PTC-
100 thermal cycler (MJ Research. INC). PCR products and
molecular weight marker were run on 2% agarose gels and
stained with Ethidium bromide.
PCR products were quantiﬁed with a densitometer
(Fluor-S MultiImager, Bio-Rad) using the Quantity One
version 4.4.1 (Bio-Rad) program. Densitometry values were
correctedusingthemouseβ-actinvalueforthesamesample.
Statistical analysis. Data regarding parasitemia, percent-
age of survival, SI, percentage of CD4+ and CD8+ cells
and cytokine/chemokine quantiﬁcation represent the values
derived from three independent experiments containing at
least 3 mice per group. Arithmetic means and standard
deviations of the means were calculated. Student’s t-test was
used to analyze the statistical signiﬁcance of the diﬀerences
observed in RT-PCR analysis. Diﬀerences were considered
statistically signiﬁcant when P ≤ .05. To analyze data regard-
ing parasitemia, cytokine levels, SI values, and percentage
of CD4+/CD8+ cells, ANOVA and X2 Test were used, with
signiﬁcance assigned for values of P ≤ .05 [31].
3. Results
Parasite infectivity was determined by blood microscopy
observation. When 1 × 104 T. cruzi BT were used, the
parasites were observed at day 3 post-infection for Qro-
infected mice and at day 7 post-infection for Ninoa infected
mice. A rapid and continuous increase in parasitemia for
both strains was observed, with blood stream parasites
reaching a peak at day 28–31 post-infection (Figure 1(a)).
Mice infected with Qro tripomastigotes showed signiﬁcantly
higher levels of blood parasitemia (2.9±0.327 million blood
tripomastigotes/mL) than the mice infected with the Ninoa
strain (1.6 ± 0.306 million blood tripomastigotes/mL) at
the peak of blood parasitemia. Nevertheless, no signiﬁcant
diﬀerences were found throughout the rest of the blood
parasitemia curve. Based on this result, the acute phase
was deﬁned as ranging from the initial infection until three
months post-infection, with the chronic phase following
immediately after. Similar results were found when 1 × 105
parasites were used (data not shown).
Importantly, signiﬁcant diﬀerences in mortality percent-
ages were observed when mice infected with diﬀerent strains
were compared. In the majority of the experiments, all
mice infected with 1 × 104 Q r oB Tw e r ek i l l e db yd a y
57 postinfection. In other experiments, the mortality rate
was 60% (data not shown). In contrast, no mortality was
observed in Ninoa-infected mice (Figure 1(b)). Macroscopic
enlarged spleen was observed in infected mice, with a
signiﬁcantdiﬀerenceinweightandsizewhencomparingQro
and Ninoa infected mice (Figure 2).
Both strains were cardiotrophic, as a number of amastig-
ote nests were observed in this organ. Lymphocyte inﬁltrates
were observed in H&E stained cardiac tissue. At day 21
post-infection, visible lymphocyte inﬁltrates were observed
in the cardiac tissue of mice infected with both strains. Some
regions also displayed visible edema. Both diﬀuse and focal
lymphocyte inﬁltrates were observed (Figure 3).
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Figure 1: Parasitemia and Survival curve in mice infected with
T. cruzi BT. Mice were inoculated ip with 1 × 104 BT Ninoa ()
or Qro () strains. (a) Parasite number in blood was determined
by counting in a Neubauer chamber using an optic microscopy.
Statistical diﬀerences in blood parasite number are indicated (∗P<
.05) at 25y 29 days post infection. (b) Survival of mice infected with
T. cruzi strains was evaluated using groups of 28 mice infected with
T. cruzi strains. Daily direct observation was done and dead mice
were recorded.
Pooled sera from 3 to 6 Ninoa- or Qro-infected mice
were tested by ELISA. Infected mice showed an increase in
speciﬁc IgG isotypes during the acute phase of infection,
reaching similar OD values by day 29 post-infection. In
Ninoa-infected mice, antibodies were detected until the
early chronic phase of the infection (80 days post-infection)
(Figure 4).
Interestingly, when antibody isotypes were determined, a
clear diﬀerence was observed. Ninoa-infected mice produced
IgM and IgG2a during the early phase of infection. Later
in the course of infection, (day 35–40 post-infection) IgG1,
IGg2b, IgG3, and IgA were produced. In contrast, Qro-
infected mice displayed a notable reduction in speciﬁc
isotype production. IgM (25 days post-infection) and IgG2a
(40 days post-infection) were the only isotypes detected in
the sera of these mice (Table 1). In western blots of sera
from Ninoa-infected mice, three main antigens (70, 45–50,
and 30kDa) were recognized by the majority of isotypes
being produced by day 20 post-infection. A fourth major
antigen (100kDa) was recognized later in the course of the
infection by IgG1 and Ig2a isotypes. Sera from Qro-infected
mice recognized antigens of 70, 40, and 35kDa (Table 1).4 Journal of Biomedicine and Biotechnology
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Figure 2: Spleen changes of mice infected with T. cruzi strains. Groups of three mice were inoculated with PBS (grey bar) or 1 × 105T.
cruzi BT of Ninoa (white bar) or Qro (black bar) strains and spleens were obtained at acute phase of infection. (a) Growth of spleen from
mice infected with Ninoa (center) and Qro (right) strains compared with control non infected mice (left). Size (b) and Weight (c) of spleen
from mice infected. Media value and standard deviation are shown. Statistical diﬀerences (P<. 001) were determined between control and
infected mice (∗) and between Ninoa and Qro strains (∗∗) by ANOVA Bonferroni post-test.
Table 1: Immunoglobulin isotype and kinetics of antigen recognized in mice infected with T. cruzi I strains.
Strain Isotype Antigens recognized (kDa) Days post-infection
20 25 30 35 40 50 60 70 80 90 100 150
Ninoa IgG1
4 5 – 5 0 XXXXXXX X X
7 0 XXXXXXX X X
100 X X X X X
IgG2a
4 5 – 5 0 XXXXXXXXX X X
7 0 XXXXXXXX X X
100 X X X X X X
IgG2b
4 5 – 5 0 XXXXXXX X X
7 0 XXXXXX X X
100 XX
IgG3 45–50 X X X X X X X X
7 0 XXXXXX X X
IgM
3 0 XXXXXXXXXX X X
4 5 – 5 0 XXXXXXXXX X X
7 0 XXXXXXXXX X X
IgA 45–50 X X X X X X X X
7 0 XXXXX X X
Qro IgG2a 70 X X
IgM 4 0 XXXXX
3 5 XXXXX
Isotype of IgG and molecular weight of antigens recognized during infection course (X) are showed in days post-infection.Journal of Biomedicine and Biotechnology 5
Table 2: Percentage of CD4+ and CD8+ lymphocytes in mice infected with T. cruzi I strains.
Strain (infection phase) Parasites CD4+ CD8+
Ninoa (acute)
PBS 28.8 ± 1 11.8 ± 0.1
1 ×104 15.1 ± 2.6∗ 11.8 ± 2.6
1 ×105 18 ± 2.5∗ 16.3 ± 1.9
Ninoa (chronic)
PBS 25.8 ± 89 . 9 ± 4.1
1 ×104 30.3 ± 11.6 23.2 ± 7.8∗
1 ×105 25.3 ± 7.4 18 ± 8.7∗
Qro (acute)
PBS 24 ± 3.3 10.5 ± 4.6
1 ×104 17 ± 3.3∗ 11.7 ± 4.3
1 ×105 14 ± 2.5∗ 10 ± 6
Mean ± standard deviation of three independent assays. Statisticaldiﬀerences between parasited and control mice are indicated (∗P<. 05). Control mice were
inoculated with phosphate buﬀer saline (PBS).
When spleen cells from acute phase mice were obtained
and stimulated with parasite antigens (20μg/mL), a signiﬁ-
cant increase in proliferative response to these antigens was
observed in both groups of infected mice. No signiﬁcant
diﬀerences were found between the SI of spleen cells from
Ninoa- or Qro-infected mice (2.9 ± 0.05 versus 2.2 ± 1,
resp.). During the chronic phase of infection, which was
only reached by Ninoa-infected mice, no diﬀerences were
observed compared to noninfected mice. When Con A was
used for stimulation, no diﬀerences were found between
infected and control mice (data not shown).
Percentages of CD4+ T lymphocytes were signiﬁcantly
lower in infected mice than in noninfected controls in the
acute phase, regardless of strain. Additionally, no diﬀerences
were found when CD8+ cells were analyzed in the acute
phase (Table 2). In the chronic phase of Ninoa infection,
the levels of CD4+ cells were reestablished, reaching levels
similar to noninfected controls. Furthermore, a signiﬁcant
percentage of CD8+ T cells were observed in Ninoa-infected
mice during the chronic phase. These phenomena were
observed independently of the initial parasite inoculums
used (Table 2).
The concentration of TH1 IL-12p40 was higher in the
blood of Qro-infected mice than in Ninoa-infected mice.
Signiﬁcant diﬀerences were observed even in the ﬁrst days
of infection. The expression of IL-12 correlated with the
expression of IFNγ, which increased signiﬁcantly within 10
days post-infection in Qro-infected mice. In Ninoa-infected
mice,IFNγ productionwasdampened,reachingamaximum
concentration eight days after Qro-infected mice (Figure 5).
With respect to the TH2 cytokines, the concentration of IL4
increased slowly, reaching a maximum concentration by day
29 post-infection in Ninoa-infected mice. A similar pattern
was observed in Qro-infected mice. With respect to IL10, we
observedaslightincreaseintheﬁrstdayofinfectionfollowed
by a decline in overall levels, with no signiﬁcant diﬀerences
observed between strains.
Because the heart is the primary site of parasite infection,
it was important to measure the concentration of the
major chemokines associated with T. cruzi infection. MCP-
1, MIP-1β, RANTES, and MIG mRNA expression in cardiac
tissue were measured during the acute phase (21 days post-
infection). In all cases, a signiﬁcant increase in chemokine
mRNA expression was observed in mice infected with either
strain. A signiﬁcant increase in the expression of MCP-1,
MIP-1β, and MIG mRNA was found in the cardiac tissue
of mice infected with Qro compared with Ninoa-infected
mice. In contrast, no diﬀerences in RANTES expression were
observed in mice infected with either strain (Figure 6).
4. Discussion
The human parasite T. cruzi contains many strains and
clones that show a great deal of genetic heterogeneity [32].
It is now accepted that T. cruzi strains can be divided into
six DTUs, T. cruzi It oV I[ 9]. As mentioned earlier, the
geographicdistributionofthesegenetictypesisdiﬀerentand
has important epidemiological implications [32, 33]. Our
group has demonstrated the existence of T. cruzi I parasites
in the domestic cycle as well as a few TCII strains in the
sylvatic cycle in Mexico [15, 16]. Furthermore, diﬀerences in
growth, metaciclogenesis and in vitro infectivity have been
demonstrated for these strains [15].
It has also been found that diﬀerent T. cruzi populations
correlate with diﬀerences in pathology observed in patients
[34]. Also, the fact that genetically similar parasite strains
can be obtained from patients with distinct clinical forms
of the disease suggests that the host immune response may
represent an important factor in determining the outcome of
infection [34, 35].
In the present study, we have shown that two genetically
similar T. cruzi I strains can possess notable diﬀerences in
their in vivo infectivity and pathogenesis as well as in the
immune response induced in a susceptible murine model.
We demonstrated that the two T. cruzi I strains analyzed
here result in diﬀerent levels of blood parasitemia, with
Qro-infected mice having double the number of parasites
observed in Ninoa-infected mice at the peak of blood
parasitemia.However,nodiﬀerenceinbloodparasitemiawas
found during other stages of infection. This phenomenon
w a so b s e r v e dw i t ht w od i ﬀerent initial inoculums. Both
strains were cardiotrophic, showing intense lymphocyte6 Journal of Biomedicine and Biotechnology
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Figure 3: Cardiac tissue histology of mice infected whit T. cruzi
strains. Mice infected with 1 × 104 parasites were sacriﬁced at day
21 post infection and heart was recovered. Tissue was ﬁxed in
4% paraformaldehyde and embedded in paraﬃn. Five μms e c t i o n s
were Hemotoxilin-Eosin stained and observed at 20× in optical
microscope. (a) Control noninfected mice, (b) Mice infected with
Ninoa strain, and (c) Mice infected with Qro strain.
inﬁltrationinthecardiactissuealongwithdiﬀuseinﬁltration
over large areas in the heart. It is worth mentioning that
the physical aspects of Qro-infected mice were diﬀerent from
Ninoa; the former presented bristly hair and paralysis of the
posterior legs. Also a signiﬁcant increase of the weight and
size of the infected mice spleen was observed.
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Figure 4: Immunoglobulin proﬁle in serum of mice infected with
T. cruzi I strains. Mice were inoculated ip with 1 × 104 T. cruzi BT
of Ninoa ()o rQ r o( ) strains. IgG antobodies were determined
by ELISA as described in materials and methods and are showed as
media value ± SD.
More important were the diﬀerences in mortality rates
that were induced by the two strains. Qro infection resulted
in 60% to 100% mortality (depending on the initial
inoculum). In contrast, Ninoa infection did not produce
signiﬁcant mortality, regardless of initial inoculum. These
results indicate an enormous diﬀerence in virulence between
these two strains. To ﬁnd a possible explanation for this
observation, the host immune response was analyzed.
In the acute phase, SI data indicated an increase in
the number of spleen cells activated by parasite antigens.
Surprisingly, in our model, no increase in CD4+ T cell
activation was observed. On the contrary, a signiﬁcant
decrease was found following infection with either strain,
conﬂicting with other previously published murine models
usingT.cruziIandT.cruziII-VIstrains[36,37].Itispossible
that macrophages, NK, and CD8 cells are responsible for
the increased levels of TH1 cytokines observed in this study,
which would agree with other murine models [21, 30,
38, 39]. In the chronic phase of Ninoa infection, recovery
of CD4+ T cells was observed, reaching similar levels to
uninfected controls. CD8+ T cell levels remained unchanged
in the acute phase and showed a signiﬁcant increase in the
chronic phase of Ninoa infection, in agreement with their
timing for expansion and contraction phases in T. cruzi
infection [40]. Furthermore, as has been recently postulated
T cruzi-speciﬁc CD8+ T cells develop in the absence of
CD4+ T cells and display similar eﬀector functions but fail
to control parasite load [41, 42].
The TH1 response was characterized by high levels of
IL-12p40 and IFNγ. Interestingly, higher concentration
and early appearance of these cytokines was only observed
in Qro-infected mice. Levels of the regulatory cytokine
I L - 1 0w e r el o wa n dl e v e l so fI L - 4p e a k e dl a t e r ,a r o u n d3 0
days post-infection. Also, chemokine proﬁles in the acute
p h a s ew e r ed i ﬀerent, with high levels of RANTES found
in mice infected either both strains, but with higher levels
of cardiac MIG, MCP-1, and MIP-1β being observed only
in Qro-infected mice. These chemokines are known to
induce production of nitric oxide in infected macrophagesJournal of Biomedicine and Biotechnology 7
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Figure 5: Serum cytokine concentration in mice infected with T. cruzi I strains. Groups of nine mice were inoculated with 1 × 104 BT Qro
()o rN i n o aB T( ). Serum was obtained from ocular plexus each 3rd day and pooled. Cytokines were measured by ELISA and presented
as average of two experiments with standard deviation. (a) IL-12 p40, (b) IFNγ, (c) IL-10, and (d) IL-4. Statistical diﬀerences between mice
infected with either strain are indicated (∗P<. 05).
[21, 43, 44]. They are also known to induce attraction of
immune cells to cardiac tissue, as has been demonstrated
with the Colombiana strain [45].
Interestingly, an enormous diﬀerencewas observed when
antibody isotypes where analyzed. The Ninoa strain induced
IgM and IgG2a in the early acute phase and IgG1, IgG2b,
IgG3, and IgA after 30 days post-infection. In contrast, the
Qro strain induced only IgM and IgG2a in the early acute
phase, with a notable diﬀerence in recognized antigens. The
presence of a higher number of isotypes in Ninoa-infected
mice could be one of the factors responsible for improved
control of parasitemia, as IgG antibodies have been related to
parasiteresistanceinmurinemodels[46,47].Interestingly,it
hasbeenreportedthatgeneticdiversitybetweenT.cruziIand
T. cruzi II-VI strains inﬂuences the immunoglobulin proﬁle
elicited during murine infection, but no diﬀerences between
T. cruzi I strains were found [48].
In the T. cruzi I infection model presented here, a
vigorous humoral response accompanied by a signiﬁcant
but moderate TH1 cellular response resulted in control of
parasitemia and limited pathology, allowing the recovery
and survival of Ninoa-infected mice. In contrast, a weak
humoral response with a potent THI proinﬂammatory
proﬁle produced an uncontrolled inﬂammatory reaction.
The decrease of CD4+ cells together with high in vitro secre-
tion of TNFα by Qro-infected J774 cells (unpublish data)
suggest that this T. cruzi strain could induce a phenomenon
similar to the toxemic state observed in severe infections,
between other pathological mechanisms that could explain
the death of Qro-infected mice [49, 50]. Studies looking for
apoptotic death of T lymphocytes and TNF and Fas ligand
measurements must be carry on with this model in order to
clarify this point.8 Journal of Biomedicine and Biotechnology
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Figure 6: mRNA expression of MIG (CXCL9), MCP-1 (CCL2),
MIP-1β (CCL4),andRantes(CCL5)incardiactissueofBalb/cmice
infected with 1 × 105 BT of T. cruzi. T o t a lR N Aw a so b t a i n e da t
day 21 post infection and chemokines expression was determined
by RT-PCR as described in material and methods. PCR products
were analyzed in 2% agarose gels stained with ethidium bromide.
Semicuantitative analysis was done. Values are average of 4 mice
from 3 independent assays. Grey bar control, black bar Ninoa strain
and White bar Qro strain. In the case of MIG and MIP-1β no
detectable levels of chemokines were found in the control tissues.
Signiﬁcant diﬀerences (∗P<. 05) in chemokine expression were
found in cardiac tissue of control versus infected mice. Diﬀerences
between T. cruzi strains were also founded (P<. 05).
As in our model, a TH1 response has been reported in
active Chiclero’s ulcer produced by Leishmania mexicana
[51], indicating that the TH1/TH2 paradigm is not always
present in these complex host-parasite relationships.
Inconclusion,intensecardiomyopathyintheacutephase
with vigorous humoral immune response, followed by the
reestablishment of CD4+ and CD8+ cells and associated
animal survival observed in Ninoa infection represents a
usefulmodelforthestudyofimmunemechanismsthatallow
the host to overcome parasite infection. On the other hand,
the highly virulent T. cruzi I Qro strain provides a useful
model to study virulence factors that result in the death of
infected mice. Additional studies should be conducted on
the T. cruzi I strains from the northern part of the American
Continent, as they are responsible for most cases of Chagas’
disease in this area.
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